Assura (LON:AGR) Earns Buy Rating from Shore Capital

Shore Capital reaffirmed their buy rating on shares of Assura (LON:AGR) in a research report sent to investors on Tuesday morning, Marketbeat reports.

Several other analysts also recently weighed in on AGR. Barclays restated an overweight rating and issued a GBX 53 ($0.67) price target on shares of Assura in a research note on Friday, February 9th. Peel Hunt cut Assura to an add rating and set a GBX 48 ($0.61) target price on the stock. in a research note on Wednesday, March 20th.

Assura Trading Up 0.8 %

LON:AGR opened at GBX 40.50 ($0.51) on Tuesday. The firm has a market capitalization of £1.21 billion, a P/E ratio of -675.00, a PEG ratio of 3.60 and a beta of 0.30. The company has a debt-to-equity ratio of 82.21, a current ratio of 1.29 and a quick ratio of 2.84. Assura has a one year low of GBX 38.38 ($0.49) and a one year high of GBX 50.75 ($0.65). The company’s 50-day simple moving average is GBX 41.67 and its 200 day simple moving average is GBX 43.54.

Assura Increases Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, July 10th. Investors of record on Thursday, June 6th will be issued a GBX 0.84 ($0.01) dividend. This is a positive change from Assura’s previous dividend of $0.82. This represents a yield of 1.97%. The ex-dividend date is Thursday, June 6th. Assura’s payout ratio is presently -5,000.00%.

Insider Activity at Assura

In other Assura news, insider Jonathan Murphy acquired 774 shares of Assura stock in a transaction that occurred on Tuesday, May 7th. The stock was bought at an average cost of GBX 42 ($0.53) per share, for a total transaction of £325.08 ($413.17). In the last three months, insiders have acquired 200,886 shares of company stock valued at $8,635,752. 0.24% of the stock is owned by corporate insiders.

Assura Company Profile

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.